Yujing Liu

4.5k citations
166 papers · 3.3k indexed · h-index 30
Topics
MicroRNA in disease regulation (10 papers)interferon and immune responses (8 papers)NF-κB Signaling Pathways (7 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Yujing Liu

158 papers receiving 3.3k citations

Peers

Yujing Liu
Comparison fields: 5 of 143
  • Molecular Biology 1.5k
  • Cancer Research 421
  • Immunology 345
  • Reproductive Medicine 266
  • Plant Science 256
Replace Snehasikta Swarnakar with:
Snehasikta Swarnakar India
Jun Tao China
Yaping Wang China
Maria Marino Italy
Maryam Majidinia Iran
Ki‐Tae Ha South Korea
Xin Jiang China
Ji‐Young Lee South Korea
Akihito Ishigami Japan
Amalia Bosìa Italy
Yujing Liu relative to Snehasikta Swarnakar India Snehasikta Swarnakar's profile →
Citations per field
00.5×2.6×
Snehasikta Swarnakar · 1×
Citations per year

Countries citing papers authored by Yujing Liu

Since Specialization
Citations

This map shows the geographic impact of Yujing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujing Liu more than expected).

Fields of papers citing papers by Yujing Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujing Liu. The network helps show where Yujing Liu may publish in the future.

Co-authorship network of co-authors of Yujing Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yujing Liu. A scholar is included among the top collaborators of Yujing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujing Liu. Yujing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 18
6 5
7 12
8 53
9 17
10 10
11 9
12 24
13
CUL4A promotes the invasion of cervical cancer cells by regulating NF-κB signaling pathway
4
14 9
15 5
16 47
17 21
18 11
19 3
20 10

About Yujing Liu

Yujing Liu is a scholar working on Cancer Research, Complementary and alternative medicine and Molecular Biology, having authored 166 papers that have together received 3.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), interferon and immune responses (8 papers) and NF-κB Signaling Pathways (7 papers). The work is most often cited by research in Reproductive Medicine (266 citations), Cancer Research (421 citations) and Molecular Biology (1.5k citations). Yujing Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jian‐Zhong Sheng, Jiexue Pan, Guolian Ding, Mengxi Guo, Hefeng Huang, Miao‐E Liu, Hong Zhou, Xuqiang Nie, Junyu Deng and Yiqiu Liu. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026